Do Increased Doses to Stem‐Cell Niches during Radiation Therapy Improve Glioblastoma Survival?
Open Access
- 1 January 2016
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2016 (1) , 8793462
Abstract
Background and Purpose. The reasons for the inevitable glioblastoma recurrence are yet understood. However, recent data suggest that tumor cancer stem cells (CSCs) in the stem‐cell niches, with self‐renewing capacities, might be responsible for tumor initiation, propagation, and recurrence. We aimed to analyze the effect of higher radiation doses to the stem‐cell niches on progression‐free survival (PFS) and overall survival (OS) in glioblastoma patients. Materials and Methods. Sixty‐five patients with primary glioblastoma treated with radiation therapy were included in this retrospective analysis. The SVZ and DG were segmented on treatment planning magnetic resonance imaging, and the dose distributions to the structures were calculated. The relationship of dosimetry data and survival was evaluated using the Cox regression analysis. Results. Conventionally fractionated patients (n = 54) who received higher doses (Dmean ≥ 40 Gy) to the IL SVZ showed improved PFS (8.5 versus 5.2 months; p = 0.013). Furthermore, higher doses (Dmean ≥ 30 Gy) to the CL SVZ were associated with increased PFS (10.1 versus 6.9 months; p = 0.025). Conclusion. Moderate higher IL SVZ doses (≥40 Gy) and CL SVZ doses (≥30 Gy) are associated with improved PFS. Higher doses to the DG, the second stem‐cell niche, did not influence the survival. Targeting the potential cancer stem cells in the SVZ might be a promising treatment approach for glioblastoma and should be addressed in a prospective randomized trial.Keywords
Funding Information
- Dietmar Hopp Stiftung
This publication has 42 references indexed in Scilit:
- Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapyNeurology, 2011
- Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant gliomaBMC Cancer, 2010
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Glioma-Associated Cancer-Initiating Cells Induce ImmunosuppressionClinical Cancer Research, 2010
- Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zoneJournal of Neuro-Oncology, 2009
- A novel tool to analyze MRI recurrence patterns in glioblastomaNeuro-Oncology, 2008
- Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotypeNeuro-Oncology, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem CellsCancer Research, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005